BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27113497)

  • 1. Clinical Improvement in a Treatment-Resistant Patient With Schizophrenia Treated With Deep Brain Stimulation.
    Corripio I; Sarró S; McKenna PJ; Molet J; Álvarez E; Pomarol-Clotet E; Portella MJ
    Biol Psychiatry; 2016 Oct; 80(8):e69-70. PubMed ID: 27113497
    [No Abstract]   [Full Text] [Related]  

  • 2. Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia.
    Damier P; Thobois S; Witjas T; Cuny E; Derost P; Raoul S; Mertens P; Peragut JC; Lemaire JJ; Burbaud P; Nguyen JM; Llorca PM; Rascol O;
    Arch Gen Psychiatry; 2007 Feb; 64(2):170-6. PubMed ID: 17283284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive high-frequency repetitive transcranial magnetic stimulation in schizophrenia: a case study.
    Sverak T; Prikryl R; Mayerova M; Anderkova L
    J ECT; 2014 Dec; 30(4):e51-3. PubMed ID: 25181021
    [No Abstract]   [Full Text] [Related]  

  • 4. Paired Pulse Depression in the Subcallosal Cingulate Region of Depression Patients.
    Srejic LR; Prescott IA; Zhang P; Strauss I; Dostrovsky JO; Giacobbe P; Kennedy SH; Lozano AM; Hamani C; Hutchison WD
    Biol Psychiatry; 2015 Jul; 78(1):e3-e4. PubMed ID: 25582268
    [No Abstract]   [Full Text] [Related]  

  • 5. Electroconvulsive therapy in treatment-resistant schizophrenia: prediction of response and the nature of symptomatic improvement.
    Chanpattana W; Sackeim HA
    J ECT; 2010 Dec; 26(4):289-98. PubMed ID: 20375701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between delay in initiating clozapine and symptomatic improvement.
    Yada Y; Yoshimura B; Kishi Y
    Schizophr Res; 2015 Oct; 168(1-2):585-6. PubMed ID: 26255084
    [No Abstract]   [Full Text] [Related]  

  • 7. Deep transcranial magnetic stimulation add-on for treatment of negative symptoms and cognitive deficits of schizophrenia: a feasibility study.
    Levkovitz Y; Rabany L; Harel EV; Zangen A
    Int J Neuropsychopharmacol; 2011 Aug; 14(7):991-6. PubMed ID: 21524336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalamic deep brain stimulation for drug-induced tremor.
    Rodrigues B; Patil PG; Chou KL
    Parkinsonism Relat Disord; 2015 Nov; 21(11):1369-70. PubMed ID: 26350120
    [No Abstract]   [Full Text] [Related]  

  • 9. Safe and Effective Electroconvulsive Therapy Using Multiple Parameters Over 5 Years in a Patient With Deep Brain Stimulator.
    Erickson JM; Carty J
    J ECT; 2015 Dec; 31(4):278-9. PubMed ID: 25856020
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of group therapy on schizophrenia.
    Malm U
    Acta Psychiatr Scand Suppl; 1982; 297():1-65. PubMed ID: 6126069
    [No Abstract]   [Full Text] [Related]  

  • 11. [Severe treatment-resistant tardive dystonia: is deep brain stimulation a treatment option].
    Mentzel CL; Tenback DE; Tijssen MA; van Harten PN
    Tijdschr Psychiatr; 2015; 57(2):125-31. PubMed ID: 25669951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep brain stimulation of the subcallosal cingulate for medication-resistant type I bipolar depression: case report.
    Torres CV; Ezquiaga E; Navas M; de Sola RG
    Bipolar Disord; 2013 Sep; 15(6):719-21. PubMed ID: 23930934
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid effects of deep brain stimulation for treatment-resistant major depression.
    Schlaepfer TE; Bewernick BH; Kayser S; Mädler B; Coenen VA
    Biol Psychiatry; 2013 Jun; 73(12):1204-12. PubMed ID: 23562618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep brain stimulation of the internal globus pallidus for refractory tardive dystonia.
    Cohen OS; Hassin-Baer S; Spiegelmann R
    Parkinsonism Relat Disord; 2007 Dec; 13(8):541-4. PubMed ID: 17236806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales.
    Wolters HA; Knegtering H; van den Bosch RJ; Wiersma D
    Schizophr Res; 2009 Jul; 112(1-3):114-8. PubMed ID: 19395241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studying schizophrenia as a neuroplastic disorder.
    Zangen A
    Can J Psychiatry; 2013 Feb; 58(2):84-5. PubMed ID: 23442894
    [No Abstract]   [Full Text] [Related]  

  • 17. Insight facilitation with add-on tDCS in schizophrenia.
    Bose A; Shivakumar V; Narayanaswamy JC; Nawani H; Subramaniam A; Agarwal SM; Chhabra H; Kalmady SV; Venkatasubramanian G
    Schizophr Res; 2014 Jun; 156(1):63-5. PubMed ID: 24767881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug therapy versus electroconvulsive therapy for refractory schizophrenia: report of a case with 14 years of follow-up.
    Dang WM; Zhou TH; Zhou M; Luo HZ; Huang WS; Kong QM; Gao LS; Yao HP; Pang J
    Int J Psychiatry Med; 2013; 45(3):245-60. PubMed ID: 24066408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of videotaped assessment in relation to a study of enhanced management in treatment-resistant schizophrenia.
    Owens DG; Finlayson A; Mercer G; Johnstone EC
    J Psychopharmacol; 1997; 11(4):357-60. PubMed ID: 9443525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term neuropsychological safety of subgenual cingulate gyrus deep brain stimulation for treatment-resistant depression.
    Bogod NM; Sinden M; Woo C; Defreitas VG; Torres IJ; Howard AK; Ilcewicz-Klimek MI; Honey CR; Yatham LN; Lam RW
    J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):126-33. PubMed ID: 24763760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.